Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Greenville › NPI 1598750721
Physician

Hunt Memorial Hospital District

Hunt Memorial Hospital District was paid $13.59M by Medicaid between Oct 2019 and Dec 2024, across 146 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoHUNT MEMORIAL HOSPITAL DISTRICT
GREENVILLE, TX 75401
33aNPI1598750721assigned 09/14/2005
33bProvider typeInternal Medicine Physician
28Total paid$13.59M
24GClaims266,718
24DCodes billed146
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers

Next to other Internal Medicine Physician providers in Texas

Rank by total paid#3 of 1,028
Median peer was paid$10K
This provider vs. median1,305×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019423$9K
20207,399$345K
202162,932$3.11M
202289,563$4.89M
202371,535$4.08M
2024incomplete34,866$1.16M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 16,592 15,983 $2.56M
99282 Emergency department visit for the evaluation and management, low to moderate severity 15% 16,161 15,629 $2.04M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 4,949 4,641 $1.84M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 8.4% 14,061 13,624 $1.14M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.6% 3,139 2,812 $1.04M
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6.8% 24,346 12,520 $925K
80053 Comprehensive metabolic panel 3.9% 16,119 14,091 $524K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.6% 14,508 13,896 $350K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 19,888 16,858 $234K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.7% 2,862 2,158 $234K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 969 912 $232K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.7% 2,513 2,371 $232K
134 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.5% 1,747 $203K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 3,699 $180K
87430 <1% 3,784 $135K
71045 Radiologic examination, chest; single view <1% 5,521 $133K
59025 Fetal non-stress test <1% 939 $104K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,867 $103K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,451 $90K
87070 <1% 2,208 $86K
70450 Computed tomography, head or brain; without contrast material <1% 1,163 $81K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,131 $74K
87081 <1% 2,431 $73K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 849 $68K
81001 <1% 7,899 $64K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,907 $62K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 408 $60K
99001 <1% 3,068 $55K
87807 <1% 1,030 $50K
83880 <1% 2,126 $42K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,245 $39K
84484 <1% 2,945 $28K
71046 Radiologic examination, chest; 2 views <1% 1,100 $27K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 531 $25K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 528 $24K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 191 $24K
99214 Doctor's office visit, returning patient (more involved) <1% 316 $23K
83690 <1% 2,635 $21K
36415 Collection of venous blood by venipuncture <1% 23,099 $19K
CP007 <1% 549 $18K
81025 <1% 1,393 $18K
77067 Screening mammography, bilateral, including computer-aided detection <1% 476 $16K
87205 <1% 1,215 $13K
77063 Screening digital breast tomosynthesis, bilateral <1% 425 $13K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,067 $13K
81003 <1% 4,090 $13K
96375 Therapeutic injection; each additional sequential IV push <1% 2,408 $12K
99213 Doctor's office visit, returning patient (routine) <1% 250 $12K
96127 <1% 179 $11K
72125 Computed tomography, cervical spine; without contrast material <1% 188 $10K
73630 <1% 303 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,065 $8K
87088 <1% 2,518 $8K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 185 $8K
87077 <1% 1,680 $7K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,468 $7K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 62 $7K
84443 Thyroid stimulating hormone (TSH) <1% 2,363 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 1,828 $7K
76775 <1% 76 $6K
96361 Intravenous infusion, hydration; each additional hour <1% 331 $6K
76830 Ultrasound, transvaginal <1% 48 $6K
87210 <1% 251 $6K
80061 Lipid panel <1% 2,407 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 12 $5K
83605 <1% 610 $5K
87186 <1% 1,240 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,632 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,284 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,118 $3K
84703 <1% 364 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 40 $3K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 114 $3K
73610 <1% 80 $3K
87040 <1% 235 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 1,960 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 22 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 173 $3K
90832 Psychotherapy session, about 30 minutes <1% 102 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 629 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 742 $2K
83735 <1% 757 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,148 $2K
85610 <1% 1,519 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 60 $2K
84702 <1% 145 $2K
73030 <1% 72 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 46 $2K
85379 <1% 231 $2K
82565 <1% 802 $2K
96376 <1% 603 $1K
86900 <1% 435 $1K
73562 <1% 46 $1K
99490 Ccm add 20min <1% 533 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 13 $1K
87185 <1% 652 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 436 $994.68
82607 <1% 428 $971.68
80164 <1% 323 $933.01
80047 <1% 159 $906.61
85730 <1% 356 $817.99
93971 <1% 14 $780.25
72131 <1% 13 $777.00
86850 <1% 53 $744.96
84112 <1% 12 $731.44
73502 <1% 12 $673.87
86901 <1% 310 $506.78
85027 <1% 116 $505.25
90715 <1% 27 $441.40
J7120 Ringers lactate infusion, up to 1000 cc <1% 188 $440.39
J1170 Injection, hydromorphone, up to 4 mg <1% 130 $288.62
J1650 Injection, enoxaparin sodium, 10 mg <1% 94 $278.99
82550 <1% 15 $264.63
0001A <1% 185 $247.35
0002A <1% 98 $243.05
74018 <1% 16 $242.44
J3010 Injection, fentanyl citrate, 0.1 mg <1% 229 $239.73
97161 <1% 13 $210.07
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 14 $207.91
82728 <1% 161 $203.35
80320 <1% 13 $177.46
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 41 $151.62
84439 <1% 184 $134.79
83540 <1% 183 $107.80
82570 <1% 173 $104.42
J2550 Injection, promethazine hcl, up to 50 mg <1% 35 $74.64
99406 <1% 15 $73.77
82043 <1% 110 $55.92
83550 <1% 79 $55.69
80069 <1% 54 $52.62
82746 <1% 53 $44.27
81002 <1% 17 $44.07
84100 <1% 16 $35.53
85651 <1% 34 $33.54
99173 <1% 15 $32.04
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 31 $29.11
92558 <1% 15 $28.50
82962 <1% 1,470 $6.69
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 12 $0.76
J2704 Injection, propofol, 10 mg 0% 344 $0.00
0012A 0% 22 $0.00
0011A 0% 25 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 0% 137 $0.00
90863 0% 32 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 22 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCOGGIN, TERRY (CHIEF FINANCIAL OFFICER)